Extraordinary General Meeting in Pharmacolog i Uppsala AB, reg. no. 556723-6418, (the “Company”), took place today, Wednesday, April 16, 2024, at 11.00 am at Clarion Hotell Gillet in Uppsala.
All decisions were made in accordance with the Board’s previously published proposal and with the required majority.
Decisions new articles of association for the company
It was resolved to change § 1 Company name in the articles of association to: “The company’s company name is Perpetua Medical AB (publ). The company is public.” In the event that the company name, for any reason, is not approved by the Swedish Companies Registration Office, the following alternative company names names in, the order indicated, will be reviewed: Perpetua Life AB (publ), Perpetua Group AB (publ) and Perpetua Holdings AB (publ).
It was resolved to change § 3 Operations in the articles of association to: “The company shall, through wholly- and partly-owned subsidiaries, develop, manufacture, market and sell products and solutions within the healthcare sector, and engage in other activities compatible therewith.”
For more information contact:
Erik Hedlund, Chairman
Email: erik.hedlund@nolsterbyinvest.se
Phone: +46 70-382 08 41
About Pharmacolog
Pharmacolog (proposed name change to Perpetua Medical AB (publ)) is a medical technology company, headquartered in Uppsala, Sweden. The company’s shares (ticker PHLOG B) are traded on Nasdaq First North Stockholm.
The following trademarks are owned and protected by Pharmacolog i Uppsala AB: Pharmacolog™-logo, WasteLog™and Pharmacolog Dashboard™.
Further information regarding the company is available at https://pharmacolog.com/.
The company’s Certified Adviser is Mangold Fondkommission AB.
Release